|
Basis of Presentation and Significant Accounting Policies (Details Textual) (USD $)
|
3 Months Ended | 9 Months Ended | 3 Months Ended | 9 Months Ended | 12 Months Ended | 9 Months Ended | 12 Months Ended | 3 Months Ended | 9 Months Ended | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Sep. 30, 2014
|
Sep. 30, 2013
|
Sep. 30, 2014
|
Sep. 30, 2013
|
Dec. 31, 2013
|
Dec. 31, 2012
|
Sep. 30, 2014
Cost of Sales [Member]
|
Sep. 30, 2013
Cost of Sales [Member]
|
Sep. 30, 2014
Cost of Sales [Member]
|
Sep. 30, 2013
Cost of Sales [Member]
|
Sep. 30, 2014
Customer Concentration Risk [Member]
|
Dec. 31, 2013
Customer Concentration Risk [Member]
|
Sep. 30, 2014
Accounts Receivable [Member]
|
Dec. 31, 2013
Accounts Receivable [Member]
|
Sep. 30, 2014
Fulton Bank [Member]
|
Dec. 31, 2013
Fulton Bank [Member]
|
Sep. 30, 2014
Bank of America [Member]
|
Dec. 31, 2013
Bank of America [Member]
|
Jun. 30, 2014
Rapid Enzymatic Assay [Member]
|
Sep. 30, 2014
Rapid Enzymatic Assay [Member]
|
Dec. 31, 2013
Rapid Enzymatic Assay [Member]
|
Sep. 30, 2014
Maximum [Member]
|
Sep. 30, 2014
Maximum [Member]
Patents [Member]
|
|
| Allowance for Doubtful Accounts Receivable | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | ||||||||||||||||||
| Cash, FDIC Insured Amount | 250,000 | ||||||||||||||||||||||
| Cash | 606,988 | 855 | 31,487 | 98,563 | 4,040 | 4,216 | |||||||||||||||||
| Concentration Risk, Percentage | 82.00% | 85.00% | 96.00% | 97.00% | |||||||||||||||||||
| Shipping, Handling and Transportation Costs | 8,440 | 9,574 | 25,677 | 32,158 | |||||||||||||||||||
| Revenue from Related Parties | 0 | 0 | 766,379 | 1,551,340 | 18,031 | 16,615 | 47,238 | 75,337 | 864,000 | ||||||||||||||
| Finite-Lived Intangible Asset, Useful Life | 17 years | ||||||||||||||||||||||
| Net Income (Loss) Available to Common Stockholders, Basic | $ (1,124,320) | $ (544,370) | $ (2,230,708) | $ (745,215) | |||||||||||||||||||
| Share-based Arrangement by Share-basedAward, Options, Grants | 175,000 | ||||||||||||||||||||||
| Stock Warrants Outstanding | 1,989 | 47,211 | 1,989 | 47,211 | 1,989 | 47,211 | |||||||||||||||||